ArticleJournal for immunotherapy of cancer2025
Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab"by Graser
Mingzhu Gao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.